author_facet Coste, Marion
De Sèze, Maëlle
Diallo, Aldiouma
Carrieri, Maria Patrizia
Marcellin, Fabienne
Boyer, Sylvie
Coste, Marion
De Sèze, Maëlle
Diallo, Aldiouma
Carrieri, Maria Patrizia
Marcellin, Fabienne
Boyer, Sylvie
author Coste, Marion
De Sèze, Maëlle
Diallo, Aldiouma
Carrieri, Maria Patrizia
Marcellin, Fabienne
Boyer, Sylvie
spellingShingle Coste, Marion
De Sèze, Maëlle
Diallo, Aldiouma
Carrieri, Maria Patrizia
Marcellin, Fabienne
Boyer, Sylvie
BMJ Open
Burden and impacts of chronic hepatitis B infection in rural Senegal: study protocol of a cross-sectional survey in the area of Niakhar (AmBASS ANRS 12356)
General Medicine
author_sort coste, marion
spelling Coste, Marion De Sèze, Maëlle Diallo, Aldiouma Carrieri, Maria Patrizia Marcellin, Fabienne Boyer, Sylvie 2044-6055 2044-6055 BMJ General Medicine http://dx.doi.org/10.1136/bmjopen-2019-030211 <jats:sec><jats:title>Introduction</jats:title><jats:p>Though Senegal has one of the highest estimated prevalence rates of chronic hepatitis B virus (HBV) infection worldwide, epidemiological data in the general population are lacking and consequences of the infection remain undocumented. The ANRS-12356 AmBASS study aims at evaluating the health and socioeconomic burden of chronic HBV infection at the individual, household and population level. Its specific objectives are (1) to document the epidemiology of chronic HBV infection, including prevalence and risk factors; (2) to assess the acceptability of home-based testing and first clinic visit; (3) to investigate the repercussions of chronic HBV infection on living conditions; and (4) to estimate the public health impact of chronic HBV infection at the population level and the feasibility of a decentralised model of HBV test and treat.</jats:p></jats:sec><jats:sec><jats:title>Methods and analysis</jats:title><jats:p>This multidisciplinary cross-sectional survey includes a twofold data collection: (1) home-based screening using dried blood spot (DBS) sampling and collection of sociodemographic, economic and behavioural data, and (2) additional clinical and biological data collection in chronic HBV carriers at the first clinic visit. The prevalence of chronic HBV infection will be estimated in the general population and in key subgroups. Risk factors for HBV acquisition in children will be explored using case-control analysis. HBV burden will be assessed through comparisons of health and economic outcomes between households affected by the disease versus non-affected households. Last, an economic evaluation will assess costs and health benefits of scaling-up HBV care.</jats:p></jats:sec><jats:sec><jats:title>Ethics and dissemination</jats:title><jats:p>This study was approved by the Senegalese National Ethical Committee for Research in Health, and received authorisation from the Senegalese Ministry of Health and the French Commission on Information Technology and Liberties (Senegalese Protocol Number: SEN17/15). The study results will be presented in peer-review journals, international conferences and at a workshop with national stakeholders in order to contribute to the design of programmes to address the HBV pandemic.</jats:p></jats:sec><jats:sec><jats:title>Trial registration number</jats:title><jats:p><jats:ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="NCT03215732" ext-link-type="clintrialgov" specific-use="clinicaltrial pre-results">NCT03215732</jats:ext-link>; Pre-results.</jats:p></jats:sec> Burden and impacts of chronic hepatitis B infection in rural Senegal: study protocol of a cross-sectional survey in the area of Niakhar (AmBASS ANRS 12356) BMJ Open
doi_str_mv 10.1136/bmjopen-2019-030211
facet_avail Online
Free
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTEzNi9ibWpvcGVuLTIwMTktMDMwMjEx
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTEzNi9ibWpvcGVuLTIwMTktMDMwMjEx
institution DE-105
DE-14
DE-Ch1
DE-L229
DE-D275
DE-Bn3
DE-Brt1
DE-Zwi2
DE-D161
DE-Gla1
DE-Zi4
DE-15
DE-Pl11
DE-Rs1
imprint BMJ, 2019
imprint_str_mv BMJ, 2019
issn 2044-6055
issn_str_mv 2044-6055
language English
mega_collection BMJ (CrossRef)
match_str coste2019burdenandimpactsofchronichepatitisbinfectioninruralsenegalstudyprotocolofacrosssectionalsurveyintheareaofniakharambassanrs12356
publishDateSort 2019
publisher BMJ
recordtype ai
record_format ai
series BMJ Open
source_id 49
title Burden and impacts of chronic hepatitis B infection in rural Senegal: study protocol of a cross-sectional survey in the area of Niakhar (AmBASS ANRS 12356)
title_unstemmed Burden and impacts of chronic hepatitis B infection in rural Senegal: study protocol of a cross-sectional survey in the area of Niakhar (AmBASS ANRS 12356)
title_full Burden and impacts of chronic hepatitis B infection in rural Senegal: study protocol of a cross-sectional survey in the area of Niakhar (AmBASS ANRS 12356)
title_fullStr Burden and impacts of chronic hepatitis B infection in rural Senegal: study protocol of a cross-sectional survey in the area of Niakhar (AmBASS ANRS 12356)
title_full_unstemmed Burden and impacts of chronic hepatitis B infection in rural Senegal: study protocol of a cross-sectional survey in the area of Niakhar (AmBASS ANRS 12356)
title_short Burden and impacts of chronic hepatitis B infection in rural Senegal: study protocol of a cross-sectional survey in the area of Niakhar (AmBASS ANRS 12356)
title_sort burden and impacts of chronic hepatitis b infection in rural senegal: study protocol of a cross-sectional survey in the area of niakhar (ambass anrs 12356)
topic General Medicine
url http://dx.doi.org/10.1136/bmjopen-2019-030211
publishDate 2019
physical e030211
description <jats:sec><jats:title>Introduction</jats:title><jats:p>Though Senegal has one of the highest estimated prevalence rates of chronic hepatitis B virus (HBV) infection worldwide, epidemiological data in the general population are lacking and consequences of the infection remain undocumented. The ANRS-12356 AmBASS study aims at evaluating the health and socioeconomic burden of chronic HBV infection at the individual, household and population level. Its specific objectives are (1) to document the epidemiology of chronic HBV infection, including prevalence and risk factors; (2) to assess the acceptability of home-based testing and first clinic visit; (3) to investigate the repercussions of chronic HBV infection on living conditions; and (4) to estimate the public health impact of chronic HBV infection at the population level and the feasibility of a decentralised model of HBV test and treat.</jats:p></jats:sec><jats:sec><jats:title>Methods and analysis</jats:title><jats:p>This multidisciplinary cross-sectional survey includes a twofold data collection: (1) home-based screening using dried blood spot (DBS) sampling and collection of sociodemographic, economic and behavioural data, and (2) additional clinical and biological data collection in chronic HBV carriers at the first clinic visit. The prevalence of chronic HBV infection will be estimated in the general population and in key subgroups. Risk factors for HBV acquisition in children will be explored using case-control analysis. HBV burden will be assessed through comparisons of health and economic outcomes between households affected by the disease versus non-affected households. Last, an economic evaluation will assess costs and health benefits of scaling-up HBV care.</jats:p></jats:sec><jats:sec><jats:title>Ethics and dissemination</jats:title><jats:p>This study was approved by the Senegalese National Ethical Committee for Research in Health, and received authorisation from the Senegalese Ministry of Health and the French Commission on Information Technology and Liberties (Senegalese Protocol Number: SEN17/15). The study results will be presented in peer-review journals, international conferences and at a workshop with national stakeholders in order to contribute to the design of programmes to address the HBV pandemic.</jats:p></jats:sec><jats:sec><jats:title>Trial registration number</jats:title><jats:p><jats:ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="NCT03215732" ext-link-type="clintrialgov" specific-use="clinicaltrial pre-results">NCT03215732</jats:ext-link>; Pre-results.</jats:p></jats:sec>
container_issue 7
container_start_page 0
container_title BMJ Open
container_volume 9
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792345571185393669
geogr_code not assigned
last_indexed 2024-03-01T17:25:14.985Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Burden+and+impacts+of+chronic+hepatitis+B+infection+in+rural+Senegal%3A+study+protocol+of+a+cross-sectional+survey+in+the+area+of+Niakhar+%28AmBASS+ANRS+12356%29&rft.date=2019-07-01&genre=article&issn=2044-6055&volume=9&issue=7&pages=e030211&jtitle=BMJ+Open&atitle=Burden+and+impacts+of+chronic+hepatitis+B+infection+in+rural+Senegal%3A+study+protocol+of+a+cross-sectional+survey+in+the+area+of+Niakhar+%28AmBASS+ANRS+12356%29&aulast=Boyer&aufirst=Sylvie&rft_id=info%3Adoi%2F10.1136%2Fbmjopen-2019-030211&rft.language%5B0%5D=eng
SOLR
_version_ 1792345571185393669
author Coste, Marion, De Sèze, Maëlle, Diallo, Aldiouma, Carrieri, Maria Patrizia, Marcellin, Fabienne, Boyer, Sylvie
author_facet Coste, Marion, De Sèze, Maëlle, Diallo, Aldiouma, Carrieri, Maria Patrizia, Marcellin, Fabienne, Boyer, Sylvie, Coste, Marion, De Sèze, Maëlle, Diallo, Aldiouma, Carrieri, Maria Patrizia, Marcellin, Fabienne, Boyer, Sylvie
author_sort coste, marion
container_issue 7
container_start_page 0
container_title BMJ Open
container_volume 9
description <jats:sec><jats:title>Introduction</jats:title><jats:p>Though Senegal has one of the highest estimated prevalence rates of chronic hepatitis B virus (HBV) infection worldwide, epidemiological data in the general population are lacking and consequences of the infection remain undocumented. The ANRS-12356 AmBASS study aims at evaluating the health and socioeconomic burden of chronic HBV infection at the individual, household and population level. Its specific objectives are (1) to document the epidemiology of chronic HBV infection, including prevalence and risk factors; (2) to assess the acceptability of home-based testing and first clinic visit; (3) to investigate the repercussions of chronic HBV infection on living conditions; and (4) to estimate the public health impact of chronic HBV infection at the population level and the feasibility of a decentralised model of HBV test and treat.</jats:p></jats:sec><jats:sec><jats:title>Methods and analysis</jats:title><jats:p>This multidisciplinary cross-sectional survey includes a twofold data collection: (1) home-based screening using dried blood spot (DBS) sampling and collection of sociodemographic, economic and behavioural data, and (2) additional clinical and biological data collection in chronic HBV carriers at the first clinic visit. The prevalence of chronic HBV infection will be estimated in the general population and in key subgroups. Risk factors for HBV acquisition in children will be explored using case-control analysis. HBV burden will be assessed through comparisons of health and economic outcomes between households affected by the disease versus non-affected households. Last, an economic evaluation will assess costs and health benefits of scaling-up HBV care.</jats:p></jats:sec><jats:sec><jats:title>Ethics and dissemination</jats:title><jats:p>This study was approved by the Senegalese National Ethical Committee for Research in Health, and received authorisation from the Senegalese Ministry of Health and the French Commission on Information Technology and Liberties (Senegalese Protocol Number: SEN17/15). The study results will be presented in peer-review journals, international conferences and at a workshop with national stakeholders in order to contribute to the design of programmes to address the HBV pandemic.</jats:p></jats:sec><jats:sec><jats:title>Trial registration number</jats:title><jats:p><jats:ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="NCT03215732" ext-link-type="clintrialgov" specific-use="clinicaltrial pre-results">NCT03215732</jats:ext-link>; Pre-results.</jats:p></jats:sec>
doi_str_mv 10.1136/bmjopen-2019-030211
facet_avail Online, Free
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTEzNi9ibWpvcGVuLTIwMTktMDMwMjEx
imprint BMJ, 2019
imprint_str_mv BMJ, 2019
institution DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1
issn 2044-6055
issn_str_mv 2044-6055
language English
last_indexed 2024-03-01T17:25:14.985Z
match_str coste2019burdenandimpactsofchronichepatitisbinfectioninruralsenegalstudyprotocolofacrosssectionalsurveyintheareaofniakharambassanrs12356
mega_collection BMJ (CrossRef)
physical e030211
publishDate 2019
publishDateSort 2019
publisher BMJ
record_format ai
recordtype ai
series BMJ Open
source_id 49
spelling Coste, Marion De Sèze, Maëlle Diallo, Aldiouma Carrieri, Maria Patrizia Marcellin, Fabienne Boyer, Sylvie 2044-6055 2044-6055 BMJ General Medicine http://dx.doi.org/10.1136/bmjopen-2019-030211 <jats:sec><jats:title>Introduction</jats:title><jats:p>Though Senegal has one of the highest estimated prevalence rates of chronic hepatitis B virus (HBV) infection worldwide, epidemiological data in the general population are lacking and consequences of the infection remain undocumented. The ANRS-12356 AmBASS study aims at evaluating the health and socioeconomic burden of chronic HBV infection at the individual, household and population level. Its specific objectives are (1) to document the epidemiology of chronic HBV infection, including prevalence and risk factors; (2) to assess the acceptability of home-based testing and first clinic visit; (3) to investigate the repercussions of chronic HBV infection on living conditions; and (4) to estimate the public health impact of chronic HBV infection at the population level and the feasibility of a decentralised model of HBV test and treat.</jats:p></jats:sec><jats:sec><jats:title>Methods and analysis</jats:title><jats:p>This multidisciplinary cross-sectional survey includes a twofold data collection: (1) home-based screening using dried blood spot (DBS) sampling and collection of sociodemographic, economic and behavioural data, and (2) additional clinical and biological data collection in chronic HBV carriers at the first clinic visit. The prevalence of chronic HBV infection will be estimated in the general population and in key subgroups. Risk factors for HBV acquisition in children will be explored using case-control analysis. HBV burden will be assessed through comparisons of health and economic outcomes between households affected by the disease versus non-affected households. Last, an economic evaluation will assess costs and health benefits of scaling-up HBV care.</jats:p></jats:sec><jats:sec><jats:title>Ethics and dissemination</jats:title><jats:p>This study was approved by the Senegalese National Ethical Committee for Research in Health, and received authorisation from the Senegalese Ministry of Health and the French Commission on Information Technology and Liberties (Senegalese Protocol Number: SEN17/15). The study results will be presented in peer-review journals, international conferences and at a workshop with national stakeholders in order to contribute to the design of programmes to address the HBV pandemic.</jats:p></jats:sec><jats:sec><jats:title>Trial registration number</jats:title><jats:p><jats:ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="NCT03215732" ext-link-type="clintrialgov" specific-use="clinicaltrial pre-results">NCT03215732</jats:ext-link>; Pre-results.</jats:p></jats:sec> Burden and impacts of chronic hepatitis B infection in rural Senegal: study protocol of a cross-sectional survey in the area of Niakhar (AmBASS ANRS 12356) BMJ Open
spellingShingle Coste, Marion, De Sèze, Maëlle, Diallo, Aldiouma, Carrieri, Maria Patrizia, Marcellin, Fabienne, Boyer, Sylvie, BMJ Open, Burden and impacts of chronic hepatitis B infection in rural Senegal: study protocol of a cross-sectional survey in the area of Niakhar (AmBASS ANRS 12356), General Medicine
title Burden and impacts of chronic hepatitis B infection in rural Senegal: study protocol of a cross-sectional survey in the area of Niakhar (AmBASS ANRS 12356)
title_full Burden and impacts of chronic hepatitis B infection in rural Senegal: study protocol of a cross-sectional survey in the area of Niakhar (AmBASS ANRS 12356)
title_fullStr Burden and impacts of chronic hepatitis B infection in rural Senegal: study protocol of a cross-sectional survey in the area of Niakhar (AmBASS ANRS 12356)
title_full_unstemmed Burden and impacts of chronic hepatitis B infection in rural Senegal: study protocol of a cross-sectional survey in the area of Niakhar (AmBASS ANRS 12356)
title_short Burden and impacts of chronic hepatitis B infection in rural Senegal: study protocol of a cross-sectional survey in the area of Niakhar (AmBASS ANRS 12356)
title_sort burden and impacts of chronic hepatitis b infection in rural senegal: study protocol of a cross-sectional survey in the area of niakhar (ambass anrs 12356)
title_unstemmed Burden and impacts of chronic hepatitis B infection in rural Senegal: study protocol of a cross-sectional survey in the area of Niakhar (AmBASS ANRS 12356)
topic General Medicine
url http://dx.doi.org/10.1136/bmjopen-2019-030211